Use of the national cancer institute community cancer centers program screening and accrual log to address cancer clinical trial accrual

Journal of Oncology Practice

Volumn 10, Issue 2, 2014, Pages

  St Germain, Diane ^a   Denicoff, Andrea M ^a   Dimond, Eileen P ^a   Carrigan, Angela ^a   Enos, Rebecca A ^a   Gonzalez, Maria M ^a   Wilkinson, Kathy ^a   Mathiason, Michelle A ^a   Duggan, Brenda ^a   Einolf, Shaun ^a   McCaskill Stevens, Worta ^a   Bryant, Donna M ^a   Thompson, Michael A ^a   Grubbs, Stephen S ^a   Go, Ronald S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SCREENING; COMORBIDITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NATIONAL CANCER INSTITUTE COMMUNITY CANCER CENTERS PROGRAM; PATIENT CARE; PATIENT REFERRAL; WORKFLOW; CLINICAL TRIAL; CLINICAL TRIAL (TOPIC); INTERVIEW; MULTICENTER STUDY; NATIONAL HEALTH ORGANIZATION; ONCOLOGY; PATIENT SELECTION; UNITED STATES;

CLINICAL TRIALS AS TOPIC; HUMANS; INTERVIEWS AS TOPIC; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); PATIENT SELECTION; UNITED STATES;

EID: 84904470440     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001194     Document Type: Article

References (29)

1. Mills EJ, Seely D, Rachlis B, et al: Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7:141-148, 2006 (Pubitemid 43159500)
2. Albrecht TL, Eggly SS, Gleason ME, et al: Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26: 2666-2673, 2008
3. Comis RL, Miller JD, Aldigé CR, et al: Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830-835, 2003 (Pubitemid 46606442)
4. Comis RL, Miller JD, Colaizzi DD, et al: Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5:50-56, 2009
5. Corrie P, Shaw J, Harris R: Rate limiting factors in recruitment of patients to clinical trials in cancer research: Descriptive study. BMJ 327:320-321, 2003 (Pubitemid 36966619)
6. Go RS, Frisby KA, Lee JA, et al: Clinical trial accrual among new cancer patients at a community-based cancer center. Cancer 106:426-433, 2006 (Pubitemid 43100454)
7. Grand MM, O'Brien PC: Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature. J Med Imaging Radiat Oncol 56:31-39, 2012
8. Lara PN Jr, Higdon R, Lim N, et al: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001 (Pubitemid 32230874)
9. Lemieux J, Goodwin PJ, Pritchard KI, et al: Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials. J Clin Oncol 26:4458-4465, 2008
10. Weckstein DJ, Thomas CA, Emery IF, et al: Assessment of perceived cost to the patient and other barriers to clinical trial participation. J Oncol Pract 7:330-333, 2011
11. Homick H: American College of Radiology Imaging Network works to address accrual issues through use of a screen failure log. Presented at the National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: Science and Solutions, Bethesda, MD, April 29, 2010
12. Kumar N, Crocker T, Smith T, et al: Challenges and potential solutions to meeting accrual goals in a phase II chemoprevention trial for prostate cancer. Contemp Clin Trials 33:279-285, 2012
13. Kaluzny A, Brawley O, Garson-Angert D, et al: Assuring access to state-of-the-art care for U.S. minority populations: The first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 85:1945-1950, 1993 (Pubitemid 23354034)
14. Lethert KH, Cheng SK, Nauman DJ, et al: Implementation of a prospective screening tool for breast cancer clinical trial eligibility at an NCI-designated cancer center. J Clin Oncol 29:397s, 2011 (suppl 15; abstr 6052)
15. Proctor JW, Martz E, Schenken LL, et al: A screening tool to enhance clinical trial participation at a community center involved in a radiation oncology disparities program. J Oncol Pract 7:161-164, 2011
16. Séroussi B, Bouaud J: Using OncoDoc as a computer-based eligibility screening system to improve accrual onto breast cancer clinical trials. Artif Intell Med 29:153-167, 2003
17. Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al: The National Cancer Institute - American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and recommendations. J Oncol Pract 9:267-276, 2013
18. National Cancer Institute - American Society of Clinical Oncology: Cancer Trial Accrual Symposium: Science and Solutions. Bethesda, MD, 2010. http://www.cancermeetings.org/TrialAccrualSymposium/programinfo.cfm
19. Commission on Cancer Program Standards 2012: Ensuring Patient-Centered Care, Version 1.2. American College of Surgeons, 2012. www.facs.org/cancer/coc/ programstandards2012.html
20. Ulrich CM, James JL, Walker EM, et al: RTOG physician and research associate attitudes, beliefs and practices regarding clinical trials: Implications for improving patient recruitment. Contemp Clin Trials 31:221-228, 2010
21. Korn EL, Freidlin B, Mooney M, et al: Accrual experience of National Cancer Institute Cooperative Group phase III trials activated from 2000 to 2007. J Clin Oncol 28:5197-5201, 2010
22. Abrams JS, Mooney MM, Zwiebel JA, et al: Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst 105:954-959, 2013
23. Scoggins JF, Ramsey SD: A national cancer clinical trials system for the 21st century: Reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst 102:1371, 2010
24. Clauser SB, Johnson MR, O'Brien DM, et al: Improving clinical research and cancer care delivery in community settings: Evaluating the NCI Community Cancer Centers Program. Implement Sci 4:63, 2009
25. Gonzalez M, Berger M, Brown T, et al: Using an online tool to understand and improve clinical trial accruals. Oncol Iss March/April:50-55, 2011
26. National Cancer Institute, Division of Cancer Treatment and Diagnosis: National Clinical Trials Network Program Guidelines (ed July 23, 2012), 2012. http://ctep.cancer.gov/investigatorResources/docs/NCTN-Program-Guidelines.pdf
27. Murthy VH, Krumholz HM, Gross CP: Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720-2726, 2004 (Pubitemid 38725421)
28. Link MP, Hagerty K, Kantarjian HM: Chemotherapy drug shortages in the United States: Genesis and potential solutions. J Clin Oncol 30:692-694, 2012
29. Metzger ML, Billett A, Link MP: The impact of drug shortages on children with cancer - the example of mechlorethamine. N Engl J Med 367:2461-2463, 2012